Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Heavy Metal Testing – V 2.0

Posted on By

Elixir Department: SOP for Heavy Metal Testing – V 2.0

Standard Operating Procedure for Heavy Metal Testing in Elixir Formulations

Department Elixir Department
SOP No. SOP/ELX/222/2025
Supersedes SOP/ELX/222/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for the qualitative and/or quantitative testing of heavy metals in elixir formulations using validated analytical methods such as ICP-MS, AAS, or colorimetric methods, in accordance with pharmacopeial and regulatory requirements.

2. Scope

This SOP applies to finished elixir products that are tested for the presence of heavy metals including, but not limited to, lead (Pb), arsenic (As), mercury (Hg), and cadmium (Cd) as part of batch release and stability studies.

3. Responsibilities

  • QC Analyst:
    • Prepare samples and standards, conduct testing, and record results.
  • QC Supervisor:
    • Verify test methods, calibration status, and ensure result accuracy.
  • QA Officer:
    • Review and approve final reports, investigate OOS results if required.
See also  Elixir Department: SOP for Sampling of Final Product for QC - V 2.0

4. Accountability

The QC Head is accountable for the execution and review of heavy metal testing procedures. The QA Head is responsible for ensuring regulatory compliance and batch release decisions based on test outcomes.

5. Procedure

5.1 Sample Preparation

  1. Take an appropriate quantity of the elixir sample (as per method SOP, typically 10–20 mL).
  2. Digest the sample using wet digestion method with nitric acid and hydrogen peroxide under a fume hood.
  3. Filter and dilute the digest to a known volume with deionized water before analysis.

5.2 Standard Preparation

  1. Prepare calibration standards for lead, arsenic, mercury, and cadmium at known concentrations as per validation protocol.
  2. Include a blank and quality control standards in each analytical run.

5.3 Instrumental Parameters (ICP-MS/AAS)

  • ICP-MS: Preferred for trace level detection; sensitivity up to ppt.
  • AAS: Use graphite furnace or hydride generation as per analyte requirement.
  • Ensure instruments are calibrated and performance-verified before use.
See also  Elixir Department: SOP for Swab Sampling for Cleaning Validation - V 2.0

5.4 Colorimetric Method (Optional)

  1. Follow USP <231> or other validated method for total heavy metal estimation (as Pb).
  2. Compare color intensity with lead reference standard after reaction with sodium sulfide or dithizone reagent.

5.5 Acceptance Criteria

  1. Heavy metal content should comply with product specification:
    • Lead (Pb): NMT 0.5 ppm
    • Arsenic (As): NMT 1.5 ppm
    • Mercury (Hg): NMT 0.1 ppm
    • Cadmium (Cd): NMT 0.2 ppm
  2. For total heavy metals (as Pb), NMT 10 ppm unless otherwise justified.

5.6 Documentation

  1. Record all data in the Heavy Metal Testing Logbook (Annexure-1).
  2. Attach chromatograms, calibration curves, and raw data to the batch file.
  3. Cross-verify results with QA before batch release.

6. Abbreviations

  • ICP-MS: Inductively Coupled Plasma Mass Spectrometry
  • AAS: Atomic Absorption Spectroscopy
  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • ppm: Parts Per Million

7. Documents

  1. Heavy Metal Testing Logbook (Annexure-1)
  2. Instrument Calibration Records
  3. Batch Manufacturing Record (BMR)

8. References

  • USP Chapter <233> – Elemental Impurities
  • ICH Q3D – Guideline for Elemental Impurities
  • 21 CFR Part 211.165 – Testing and Release for Distribution

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Heavy Metal Testing Logbook

Date Batch No. Pb (ppm) As (ppm) Hg (ppm) Cd (ppm) Method Tested By Verified By
11/04/2025 ELX-0425-040 0.3 0.8 <0.05 0.1 ICP-MS Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Inclusion of ICP-MS and updated limits per ICH Q3D Regulatory Alignment QA Head
See also  Elixir Department: SOP for Preservative Effectiveness Testing - V 2.0
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: SOP for Development of Uniformity of Mass Method – V 2.0
Next Post: Aligning SOP Updates With Regulatory Guidance Documents

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version